Brain chemical targeted to ease autism social struggles
NCT ID NCT05063656
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether gabapentin, a medication that boosts a calming brain chemical called GABA, could improve social thinking in teens with autism. Sixteen adolescents aged 13-17 took gabapentin for 8 weeks while researchers measured brain GABA levels and social abilities. The goal was to see if correcting a brain chemical imbalance could ease social difficulties.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug calm irritability in kids with autism?
- Can a Four-Week program ease the burden on autism caregivers?
- Video games as therapy: can exergaming boost motor skills in autistic youth?
- Can a 'Plan-Do-Check' method help kids with autism master daily tasks?
- Can a 12-Week play program boost development in At-Risk infants?
- Autism and self-awareness: a study tests whether questionnaires capture personality traits accurately